Column for the date, column for the dose, column for weight, and a messy column for how I felt
However, appropriate use extends beyond FDA label indications
Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)
Patients using compounded GLP-1s pay out-of-pocket
While it's essential to recognize that the FDA does not endorse off-label use, the demand for Ozempics weight loss magic couldn't be ignored, leading to practitioners across the country taking the obesity fight into their own handsor prescription pads
How quickly it degrades depends almost entirely on three factors: temperature, light exposure, and bacterial contamination